Oskar Möbert, vice president, OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engageme
Companies seek efficiency and speed to market during the content creation process, review and approval cycles, and thus the collective time for content to be approved for d
Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketin
A new poll of clinical trial sponsors has found that around nine out of 10 of them are running decentralised trials with the help of digital technologies, a big increase on pre-COVID-19 lev
Rapid creation of compliant marketing content is increasingly important and there are ways emerging pharma companies can stay ahead of the game - despite having fewer resources than bigger